David A. Hosford
2012
In 2012, David A. Hosford earned a total compensation of $520.2K as Vice President, Clinical Development and Regulatory Affairs at Catalyst Biosciences.
Compensation breakdown
| Bonus | $10,132 |
|---|---|
| Non-Equity Incentive Plan | $3,377 |
| Option Awards | $226,493 |
| Salary | $270,180 |
| Other | $10,000 |
| Total | $520,182 |
Hosford received $270.2K in salary, accounting for 52% of the total pay in 2012.
Hosford also received $10.1K in bonus, $3.4K in non-equity incentive plan, $226.5K in option awards and $10K in other compensation.
Rankings
In 2012, David A. Hosford's compensation ranked 8,642nd out of 11,487 executives tracked by ExecPay. In other words, Hosford earned more than 24.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,642 out of 11,487 | 25th |
Division Manufacturing | 3,137 out of 4,253 | 26th |
Major group Chemicals And Allied Products | 842 out of 1,203 | 30th |
Industry group Drugs | 617 out of 925 | 33rd |
Industry Pharmaceutical Preparations | 480 out of 700 | 31st |
Source: SEC filing on April 18, 2014.
Hosford's colleagues
We found six more compensation records of executives who worked with David A. Hosford at Catalyst Biosciences in 2012.
2012
Stephen Hill
Catalyst Biosciences
Chief Executive Officer
2012
Jeffrey Brennan
Catalyst Biosciences
Former Senior Vice President, Business and Commercial Development and Chief Business Officer
2012
Alan Musso
Catalyst Biosciences
Chief Financial Officer
2012
Peter Zorn
Catalyst Biosciences
General Counsel
2012
J deBethizy
Catalyst Biosciences
Chief Executive Officer
2012
Mark Skaletsky
Catalyst Biosciences